| $385M | ||
| $350M | ||
| $215M | ||
| $100M | ||
| $88M | ||
| $62M |
Buys | $43,836,986 | 27 | 93 |
Sells | $53,318 | 2 | 7 |
| COLUMN GROUP III GP, LP | 10 percent owner | 10 | $35.98M | 0 | $0 | $35.98M |
| Kutzkey Tim | 9 | $5.98M | 0 | $0 | $5.98M | |
| TCG Crossover GP II, LLC | 10 percent owner | 8 | $1.87M | 0 | $0 | $1.87M |
| Li Yang | Exec. Vice President, Research | 0 | $0 | 1 | $22,209 | $-22,209 |
| Williams Charles O | Chief Operating Officer | 0 | $0 | 1 | $31,109 | $-31,109 |
Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. It is developing tissue-specific antibodies with application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system. Its products in pipeline include SZN-043 a tissue-specific R-spondin mimetic for the treatment of severe liver disease; and SZN-1326, a bi-specific full-length human antibody that directly modulates Wnt signaling in target tissue by binding to particular Frizzled and LRP receptors that are expressed in intestinal crypts. Surrozen, Inc. was founded in 2015 and is headquartered in South San Francisco, California.
Over the last 12 months, insiders at Surrozen, Inc. have bought $43.84M and sold $53,318 worth of Surrozen, Inc. stock.
On average, over the past 5 years, insiders at Surrozen, Inc. have bought $24.94M and sold $44,238 worth of stock each year.
Highest buying activity among insiders over the last 12 months: COLUMN GROUP III GP, LP (10 percent owner) — $35.98M. Kutzkey Tim () — $5.98M. TCG Crossover GP II, LLC (10 percent owner) — $1.87M.
The last purchase of 1,190 shares for transaction amount of $29,733 was made by TCG Crossover GP II, LLC (10 percent owner) on 2026‑03‑16.
| 2026-03-16 | TCG Crossover GP II, LLC | 10 percent owner | 1,190 0.0136% | $24.99 | $29,733 | +2.06% | ||
| 2026-03-13 | TCG Crossover GP II, LLC | 10 percent owner | 35,433 0.4079% | $24.88 | $881,463 | +2.50% | ||
| 2026-03-12 | TCG Crossover GP II, LLC | 10 percent owner | 12,374 0.1393% | $24.99 | $309,166 | |||
| 2026-02-12 | TCG Crossover GP II, LLC | 10 percent owner | 1,093 0.0122% | $23.86 | $26,082 | +10.75% | ||
| 2026-02-11 | TCG Crossover GP II, LLC | 10 percent owner | 17,763 0.1986% | $23.57 | $418,763 | +10.87% | ||
| 2026-02-03 | TCG Crossover GP II, LLC | 10 percent owner | 4,355 0.0483% | $21.94 | $95,549 | +14.95% | ||
| 2026-02-02 | TCG Crossover GP II, LLC | 10 percent owner | 731 0.0081% | $21.38 | $15,629 | +11.26% | ||
| 2026-01-30 | TCG Crossover GP II, LLC | 10 percent owner | 4,271 0.0495% | $21.39 | $91,357 | +23.08% | ||
| 2026-01-20 | Kutzkey Tim | 18,052 0.2296% | $19.60 | $353,817 | +37.00% | |||
| 2026-01-20 | COLUMN GROUP III GP, LP | 10 percent owner | 18,052 0.2296% | $19.60 | $353,817 | +37.00% | ||
| 2026-01-16 | Kutzkey Tim | 2,562 0.0299% | $20.00 | $51,240 | +21.90% | |||
| 2026-01-16 | COLUMN GROUP III GP, LP | 10 percent owner | 2,562 0.0299% | $20.00 | $51,240 | +21.90% | ||
| 2026-01-15 | Kutzkey Tim | 11,893 0.138% | $19.89 | $236,540 | +21.35% | |||
| 2026-01-15 | COLUMN GROUP III GP, LP | 10 percent owner | 11,893 0.138% | $19.89 | $236,540 | +21.35% | ||
| 2026-01-14 | Kutzkey Tim | 5,523 0.0644% | $19.99 | $110,395 | +20.80% | |||
| 2026-01-14 | COLUMN GROUP III GP, LP | 10 percent owner | 5,523 0.0644% | $19.99 | $110,395 | +20.80% | ||
| 2026-01-13 | Kutzkey Tim | 12,470 0.1395% | $19.80 | $246,957 | +16.61% | |||
| 2026-01-13 | COLUMN GROUP III GP, LP | 10 percent owner | 12,470 0.1395% | $19.80 | $246,957 | +16.61% | ||
| 2026-01-06 | Kutzkey Tim | 15,100 0.1834% | $19.89 | $300,297 | +21.76% | |||
| 2026-01-06 | COLUMN GROUP III GP, LP | 10 percent owner | 15,100 0.1834% | $19.89 | $300,297 | +21.76% |
| Kutzkey Tim | 1016658 11.861% | $25.92M | 10 | 0 | <0.0001% | |
| COLUMN GROUP III GP, LP | 10 percent owner | 1016658 11.861% | $25.92M | 11 | 0 | <0.0001% |
| TCG Crossover GP II, LLC | 10 percent owner | 675613 7.8822% | $17.23M | 8 | 0 | |
| Li Yang | Exec. Vice President, Research | 16091 0.1877% | $410,320.50 | 0 | 2 | |
| Williams Charles O | Chief Operating Officer | 12982 0.1515% | $331,041.00 | 1 | 2 | <0.0001% |
| Consonance Capman GP, LLC | director | 500000 5.8333% | $12.75M | 1 | 0 | |
| BLUTT MITCHELL J MD | director | 434000 5.0633% | $11.07M | 2 | 1 | |
| Consonance Life Sciences | director | 434000 5.0633% | $11.07M | 2 | 1 | |
| Livingston Kevin Harold | Chief Financial Officer | 434000 5.0633% | $11.07M | 2 | 1 | |
| Soffer Benny | director | 434000 5.0633% | $11.07M | 2 | 1 | |
| Parker Craig C | Chief Executive Officer | 1474 0.0172% | $37,587.00 | 1 | 0 | <0.0001% |
$22,693,451 | 105 | 8.15% | $205.02M | |
$26,922,905 | 100 | 5.55% | $238.29M | |
$8,708,580 | 93 | -5.38% | $238.16M | |
$87,639,490 | 62 | 18.37% | $254.57M | |
$6,915,275 | 21 | -32.61% | $209.15M | |
$38,821,584 | 20 | -2.17% | $197.02M | |
$4,701,608 | 14 | -4.34% | $230.81M | |
$135,812,721 | 14 | 17.52% | $195.8M | |
$170,425 | 10 | -16.01% | $256.91M | |
$6,847,110 | 9 | 5.96% | $248.59M | |
$5,905,507 | 7 | 2.69% | $208.29M | |
$99,355,998 | 7 | -65.74% | $202.32M | |
$272,982 | 6 | -28.53% | $223.58M | |
$8,286,963 | 6 | 3.09% | $214.89M | |
$556,839 | 5 | 13.42% | $226.12M | |
$20,729,984 | 5 | 51.71% | $199.98M | |
Surrozen, Inc. (SRZN) | $6,049,986 | 4 | -8.38% | $218.57M |
$32,007,657 | 4 | -45.65% | $210.36M | |
$32,289,200 | 3 | -5.46% | $243.9M |
| Increased Positions | 43 | +153.57% | 4M | +59.95% |
| Decreased Positions | 9 | -32.14% | 1M | -18.48% |
| New Positions | 25 | New | 2M | New |
| Sold Out Positions | 7 | Sold Out | 944,382 | Sold Out |
| Total Postitions | 62 | +121.43% | 9M | +41.47% |
| Column Group Llc | $32,320.00 | 16.66% | 1.5M | 0 | 0% | 2025-09-30 |
| Stempoint Capital Lp | $15,375.00 | 7.93% | 713,463 | +26,924 | +3.92% | 2025-09-30 |
| Vr Adviser, Llc | $13,640.00 | 7.03% | 632,931 | 0 | 0% | 2025-09-30 |
| Ra Capital Management, L.P. | $12,987.00 | 6.7% | 602,626 | 0 | 0% | 2025-09-30 |
| 5Am Venture Management, Llc | $6,681.00 | 3.44% | 310,000 | 0 | 0% | 2025-09-30 |
| Vanguard Group Inc | $5,741.00 | 2.96% | 266,418 | +47,468 | +21.68% | 2025-09-30 |
| Vivo Capital, Llc | $5,603.00 | 2.89% | 260,000 | 0 | 0% | 2025-09-30 |
| Stonepine Capital Management, Llc | $5,391.00 | 2.78% | 250,146 | -55,883 | -18.26% | 2025-09-30 |
| Samsara Biocapital, Llc | $5,202.00 | 2.68% | 241,400 | 0 | 0% | 2025-09-30 |
| Nantahala Capital Management, Llc | $4,946.00 | 2.55% | 229,527 | 0 | 0% | 2025-09-30 |